Insights on Health Care
1231 total results. Page 37 of 50.
In late December 2017, the Office of Inspector General (OIG) of the Department of Health and Human Services (HHS) released the findings of a report titled “Potential Misclassifications Reported by Drug Manufacturers May Have Led to $1 Billion in Lost Medicaid Rebates.”
Bloomberg BNA’s Health Law Reporter provided an in-depth overview of the issues that likely will test health care lawyers in 2018 based on commentary from Bloomberg Law’s Health Care Advisory Board of which health care partner Lowell Brown is a member.
The Department of Justice recently published its annual False Claims Act (FCA) recoveries statistics for Fiscal Year 2017, reporting $3.7 billion in FCA settlements and judgments in FY 2017.
Arent Fox LLP is pleased to announce the election of 10 new partners and two new counsel, effective January 1, 2018.
The Pharmaceutical Research and Manufacturers of America (PhRMA) filed a lawsuit against the state of California in response to the state’s new drug price law.
On December 8, 2017, the Pharmaceutical Research and Manufacturers of America (PhRMA) filed a lawsuit in the US District Court for the Eastern District of California seeking to block California’s new drug transparency law.
The world of health care reimbursement can involve many different players on the payer side. Group health plans and health insurers are well-known players, but networks, administrators, repricers, consultants, and others may enter the scene as well.
Arent Fox Health Care Partner David Greenberg recently published an article in Bloomberg Law discussing health care reform, specifically focusing on the Medicaid program and how innovations currently in place in Indiana may serve as the model for Medicaid reform.
California agencies posted their proposed emergency regulations for commercial medicinal and adult-use cannabis.
On November 8, 2017, the Federal Trade Commission held a workshop entitled, “Understanding Competition in Prescription Drug Markets: Entry and Supply Chain Dynamics.”
The advance copy of the Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems and Quality Reporting Programs (HOPPS) final rule for calendar year 2018 (the Final Rule) was released on November 1, 2017.
Twenty-two Arent Fox LLP practices have been recognized in the 2018 “Best Law Firms” rankings that are published annually by U.S. News & World Report and Best Lawyers.
California Governor Jerry Brown signed two major pieces of legislation affecting the application and hiring process for nearly all employees. AB 168 prohibits employers from seeking salary history information about an applicant for employment, among its related provisions.
Following in the steps of Maryland and Nevada, California just adopted a comprehensive drug pricing transparency law that will have a significant impact on the pharmaceutical industry, particularly on drug manufacturers. n
In August 2016, the Food and Drug Administration issued a final rule to update and clarify the agency’s drug registration and listing regulations.
Health care providers increasingly seek advice from attorneys on navigating the distinct forms of self-disclosure to government agencies for regulatory missteps.
Legislation is moving forward that could potentially ease the penalties associated with alleged violations of the physician self-referral (Stark) law.
The issue of where a medical provider with an assignment of benefits may sue an ERISA-governed healthcare plan for unreimbursed medical care is important.
On August 21, 2017, the Health Resources and Services Administration published a proposed rule that would entertain even further delays of the implementation of a January 5, 2017 Final Rule regarding calculation of 340B ceiling prices.
Arent Fox partner and national leader of the Health Care group Lowell Brown was quoted in the Modern Healthcare article, “C-suite pay raises target transformational healthcare leaders,” on executive compensation among health systems.
Forty-two Arent Fox LLP attorneys have been rated as leaders in their profession by The Best Lawyers in America 2018.
Arent Fox former Senator and Congressman, respectively, discussed a newly released report that shows the benefits of group purchasing organizations on the cost of health care.
On July 18, 2017, FDA held a public meeting to address efforts to ensure a balance between innovation in drug development and accelerating the access of the public to lower-cost alternatives to innovator drug therapies is maintained under the Drug Price Competition and Patent Term Restoration Act.
The Centers for Medicare & Medicaid Services has released its annual proposed update to the hospital outpatient prospective payment system for calendar year 2018.
Health Care Partner Tom Jeffry and 44 other health care executives spoke to Becker’s Hospital Review about the key trends disrupting the traditional hospital and how institutions can prepare for the future.